Convergent and divergent effects of costimulatory molecules in conventional and regulatory CD4+ T cells

Costimulatory molecules of the CD28 family on T lymphocytes integrate cues from innate immune system sensors and modulate activation responses in conventional CD4+ T cells (Tconv) and their FoxP3+ regulatory counterparts (Treg). To better understand how costimulatory and coinhibitory signals might be integrated, we profiled the changes in gene expression elicited in the hours and days after engagement of Treg and Tconv by anti-CD3 and either anti-CD28, -CTLA4, -ICOS, -PD1, -BLA, or -CD80. In Tconv, a shared “main response” was induced by CD28, ICOS, and, surprisingly, BTLA and CD80, with very limited CD28-specific (primarily Il2) or ICOS-specific elements (including Th1 and Th2 but not the follicular T signature). CTLA4 and PD1 had a very subtle impact in this system, similarly inhibiting the response to anti-CD3. Treg responded to the same costimulatory hierarchy and to the same extent as Tconv, but inducing different clusters of genes. In this reductionist system, costimulatory or coinhibitory engagement mainly elicits generic responses, suggesting that the variability of their effects in vivo result from temporal or anatomical differences in their engagement, rather than from inherently different wiring.

[1]  Jonathan S. Paw,et al.  Treating Human Autoimmunity: Current Practice and Future Prospects , 2012, Science Translational Medicine.

[2]  L. Walker,et al.  The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses , 2011, Nature Reviews Immunology.

[3]  S. Quezada,et al.  Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication , 2011, Immunological reviews.

[4]  Burton E. Barnett,et al.  Germinal Center T Follicular Helper Cell IL-4 Production Is Dependent on Signaling Lymphocytic Activation Molecule Receptor (CD150) , 2010, The Journal of Immunology.

[5]  Christophe Benoist,et al.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.

[6]  S. Quezada,et al.  Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). , 2010, Current opinion in immunology.

[7]  Sudha Kumari,et al.  Protein Kinase C-θ Mediates Negative Feedback on Regulatory T Cell Function , 2010, Science.

[8]  K. Murphy,et al.  Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. , 2010, Annual review of immunology.

[9]  J. Bluestone,et al.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells , 2009, Immunological reviews.

[10]  R. Nurieva,et al.  Yin–Yang of costimulation: crucial controls of immune tolerance and function , 2009, Immunological reviews.

[11]  J. Riley.  PD‐1 signaling in primary T cells , 2009, Immunological reviews.

[12]  H. Schneider,et al.  CD28 and CTLA‐4 coreceptor expression and signal transduction , 2009, Immunological reviews.

[13]  G. Freeman,et al.  Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. , 2007, Immunity.

[14]  K. Murphy,et al.  Unexpected Role of B and T Lymphocyte Attenuator in Sustaining Cell Survival during Chronic Allostimulation , 2007, The Journal of Immunology.

[15]  L. Turka,et al.  Defective Activation of Protein Kinase C and Ras-ERK Pathways Limits IL-2 Production and Proliferation by CD4+CD25+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[16]  K. Murphy,et al.  Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA. , 2006, Biochemical and Biophysical Research Communications - BBRC.

[17]  N. Câmara,et al.  Altered proximal T cell receptor (TCR) signaling in human CD4+CD25+ regulatory T cells , 2006, Journal of leukocyte biology.

[18]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[19]  A. Lanfranco,et al.  CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms , 2004, Molecular and Cellular Biology.

[20]  P. Linsley,et al.  Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Ash A. Alizadeh,et al.  Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Freeman,et al.  The B7–CD28 superfamily , 2002, Nature Reviews Immunology.

[23]  D. Olive,et al.  Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling , 1994, Nature.

[24]  D. Olive,et al.  Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling , 1994, Nature.

[25]  L. Lanier,et al.  Functional expression of B7/BB1 on activated T lymphocytes , 1993, The Journal of experimental medicine.

[26]  C. Thompson,et al.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.